Article
Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility
6 Nov 2017
Abstract excerpt
ABSTRACT Staphylococcus aureus is a major human pathogen whose infections are increasingly difficult to treat due to increased antibiotic resistance, including resistance to vancomycin. Vancomycin-intermediate S. aureus (VISA) strains develop resistance to vancomycin through adaptive changes that are incompletely understood. Central to this adaptation are metabolic changes that permit growth in the presence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
